Colorectal Cancer

16 competing products in clinical development for Colorectal Cancer.

Pipeline by Phase

Phase 13
Phase 1/23
Phase 27
Phase 2/33

All Products (16)

ProductCompanyStageStatusHype
ONO-4578 + Opdivo® + Oxaliplatin + 5-Fluorouracil + Bevacizumab + LeucovorinOno PharmaceuticalPhase 2Recruiting
42
FOLFIRI + FOLFOX-4 + FOLFIRI-HD + FOLFOX-7 + FOLFIRINOXChugai PharmaceuticalPhase 2/3Completed
38
CPT-11 and TS-1 + CPT-11, 5-FU and l-LVDaiichi SankyoPhase 2/3Completed
38
Nivolumab + Oxaliplatin + Leucovorin + Fluorouracil + BevacizumabOno PharmaceuticalPhase 2/3Completed
38
Cetuximab + Oxaliplatin + CapecitabineEli LillyPhase 2Completed
35
ALIMTA + OxaliplatinEli LillyPhase 2Completed
35
CS7017 + irinotecan, leucovorin, and 5-fluorouracil (5-FU) (FOLFIRI)Daiichi SankyoPhase 2Completed
35
DJ-927Daiichi SankyoPhase 2Completed
35
E7070EisaiPhase 2Completed
35
ONO-4578 + ONO-4538 + Capecitabine + Oxaliplatin + Fluorouracil + Calcium Levofolinate Hydrateb + BevacizumabOno PharmaceuticalPhase 1Active
33
Bevacizumab + Oxaliplatin + CapecitabineChugai PharmaceuticalPhase 1/2Completed
32
Dacogen™ (decitabine) + Vectibix® (panitumumab)EisaiPhase 1Completed
29
KRN330Kyowa KirinPhase 1Completed
29
CS-7017 + PlaceboDaiichi SankyoPhase 2Terminated
27
FOLFIRI + E7820 + BevacizumabEisaiPhase 1/2Terminated
24
KRN330 + IrinotecanKyowa KirinPhase 1/2Terminated
24